Study ID: BDP-AR-304
Study Title
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Female, Maleergic Rhinitis (PAR)
Teva Identifier
- BDP-AR-304
ClinicalTrials.gov Identifier
- NCT01133626
Study Status
- Completed
Trial Condition(s)
- Perennial Female, Maleergic Rhinitis
Interventions
- Drug: Placebo Nasal Aerosol | Drug: Prednisone capsules | Drug: Placebo Prednisone Capsules | Drug: Beclomethasone dipropionate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years to 45 Years
Trial Duration
- 06/01/2010 - 09/01/2010
Phase
- Phase 3
Study Type
Interventional
